Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

Autor: Touraine, P, D'Souza, Ga, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres Vela, E, Ekman, B, GH Lipoatrophy Study Group, Andersen, M, Beck Peccoz, P, Beckers, A, Bex, Ma, Bornstein, Sr, Cannavo', Salvatore, Cap, J, Chanson, P, Colao, Am, Faust, M, Halperin, I, Karbownik Lewinska, M, De Marinis, L, Drake, Wm, Erfurth, Em, Ghigo, E, Hana, V, Kann, Ph, Laurberg, P, Miell, Jp, Milewicz, A, Payer, J, Pereira, Am, T'Sjoen, G, Sowinski, J, Stalla, Gk, Trainer, Pj, Wass, J, Brue, T, Casanueva, Ff, Czernichow, P, Delemer, B, De Schepper, J, Feldt Rasmussen, U, Gregory, Jw, Jørgensen, Jo, Johannsson, G, Kristensen, Lo, Mattsson, C, Pura, M, Vanuga, P.

Publikováno v: European journal of endocrinology
Andersen, M & GH Lipoatrophy Study Group 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-540 . https://doi.org/10.1530/EJE-09-0422
Touraine, P, D'Souza, G A, Kourides, I, Abs, R, Barclay, P, Xie, R, Pico, A, Torres-Vela, E, Ekman, B, GH Lipoatrophy Study Group & Jørgensen, J O L 2009, ' Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH ', European Journal of Endocrinology, vol. 161, no. 4, pp. 533-40 . https://doi.org/10.1530/EJE-09-0422

ObjectiveChanges observed during adult GH deficiency (GHD) are most often reversed with the administration of recombinant human GH (rhGH). To avoid daily injections, a long-acting GH molecule has been obtained by covalent binding of polyethylene glyc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea4a0935162993021717df6387b9837
https://hdl.handle.net/10067/799280151162165141

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Inhaled human insulin treatment in patients with type 2 diabetes mellitus.

Autor: Cefalu, William T., Skyler, Jay S., Kourides, Ione A., Landschulz, William H., Balagtas, Cecile C., Shu-Lin Cheng, Gelfand, Robert A., Cefalu, W T, Skyler, J S, Kourides, I A, Landschulz, W H, Balagtas, C C, Cheng, S, Gelfand, R A, Inhaled Insulin Study Group

Publikováno v: Annals of Internal Medicine; 02/06/2001, Vol. 134 Issue 3, p203-207, 5p, 3 Graphs

Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM. Results of two multicenter, randomized, placebo-controlled clinical trials. The Glipizide Gastrointestinal Therapeutic System Study Group.

Autor: Simonson DC, Kourides IA, Feinglos M, Shamoon H, Fischette CT, Simonson, D C, Kourides, I A, Feinglos, M, Shamoon, H, Fischette, C T

Publikováno v: Diabetes Care; Apr1997, Vol. 20 Issue 4, p597-606, 10p